StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO)
Equities researchers at StockNews.com started coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “hold” rating on the medical research company’s stock. CTSO has been the topic of several other reports. D. Boral Capital reissued a “buy” rating and set a […]
Equities researchers at StockNews.com started coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “hold” rating on the medical research company’s stock. CTSO has been the topic of several other reports. D. Boral Capital reissued a “buy” rating and set a […]
